Telemonitoring of Type 2 Diabetes Mellitus in Italy
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type 2 diabetes mellitus (DM) affects 382 million people worldwide. INTRODUCTION: This study aimed at assessing whether telemonitoring (TM) of DM patients improves health-related quality of life (HRQoL). MATERIALS AND METHODS: As part of the RENEWING HEALTH project, 299 DM patients with HbA1c >7.0% were enrolled in a randomized controlled trial, with 208 patients in the TM group and 91 patients in the usual-care group. TM electronically transmitted glucose measurements to physicians during a 12-month follow-up. The SF-36v2 questionnaire was used to assess HRQoL. RESULTS: In a total of 243 patients analyzed, the study did not identify any clinically important improvement in HRQoL, our primary endpoint. There was no statistically significant difference in HbA1c between the two groups; however, outpatient visits and planned hospitalizations were significantly reduced in the TM group (p < 0.0001 and p = 0.02). DISCUSSION: The results regarding HRQoL might be, at least in part, an artifact stemming from the criteria used to select patients. TM reduced ambulatory visits and planned hospital admissions, an important result that plausibly reflects the fact that clinicians can strictly monitor their patients' health status without face-to-face contacts. CONCLUSIONS: Enhancement of HRQoL should represent the most critical goal of DM healthcare delivery. Effects of TM on HRQoL of diabetic patients should be studied further.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642
Wilson, I. B. (1995) · JAMA · doi:10.1001/jama.1995.03520250075037 · Cited by 3,027
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Hinz, A., & Brähler, E. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.01.005 · Cited by 413
Paré, G., Moqadem, K., Pineau, G., & St-Hilaire, C. (2010) · Journal of Medical Internet Research · doi:10.2196/jmir.1357 · Cited by 261
Home telehealth reduces healthcare costs
Noel, H. C., Vogel, D. C., Erdos, J. J., Cornwall, D., & Levin, F. (2004) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2004.10.170 · Cited by 258
Research works printed but not linked: 24
- 10.2337/dc14-0817 · DOI · Paper page
- 10.1016/S0140-6736(15)60692-4 · DOI · Paper page
- 10.1089/tmj.2008.0021 · DOI · Paper page
- Singer B, 2001, New horizons in health: An integrative approach
- 10.1186/1477-7525-2-32 · DOI
- Spilker B, 1996, Quality of life and pharmaco economics in clinical trials
- 10.1007/s11548-011-0613-1 · doi:10.1007/s11548-011-0613-1
- 10.1017/S0266462311000638 · DOI · Paper page
- Lesaffre E, 2008, Bull NYU Hosp Jt Dis, 66, 150
- 10.1002/0471740136 · DOI · Paper page
- Pocock SJ, 1983, Clinical trials—A practical approach
- 10.1002/0471722103 · DOI · Paper page
- 10.1111/j.1600-0447.1983.tb09716.x · DOI · Paper page
- Maruish ME, User's manual for the SF-36v2 Health Survey
- Paré G, 2009, ETMIS, 5, 1
- 10.2337/diacare.26.5.1475 · DOI · Paper page
- 10.2337/diacare.22.7.1125 · DOI · Paper page
- 10.2337/dc15-ti01 · DOI
- 10.1056/NEJMoa0802743 · DOI · Paper page
- 10.3109/02813432.2011.585542 · DOI
- 10.1097/00005650-199412000-00002 · DOI · Paper page
- 10.2337/diabetes.52.1.102 · DOI · Paper page
- 10.1097/00005650-198903001-00018 · DOI · Paper page
- Polonsky WH, 2000, Diabetes Spectrum, 13, 36
Cited by
Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis
De Groot, J., Wu, D., Flynn, D., Robertson, D., Grant, G., & Sun, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i2.170 · Cited by 77
Leo, D. G., Buckley, B. J. R., Chowdhury, M., Harrison, S. L., Isanejad, M., Lip, G. Y. H., Wright, D. J., Lane, D. A., & the TAILOR investigators (2022) · Journal of Medical Internet Research · doi:10.2196/35508 · Cited by 62
“The duration of the interval before and after varied, with 18% (2/11) of these studies reporting a 6-week assessment [58,87], 45% (5/11) [27,30,46,49,63] reporting 3-month assessments, 9% (1/11) reporting 9-month assessments [109], and 27% (3/11) [35,89] reporting 12-month assessments.”
InfluentialShen, Y., Wang, F., Zhang, X., Zhu, X., Sun, Q., Fisher, E., & Sun, X. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9133 · Cited by 54
“In unclear group [8,12,16,26,38,42,45,47], difference in HbA1c outcomes was not significant as P=.”
BackgroundMethodInfluentialHangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., & Udsen, F. W. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211064633 · Cited by 55
Robson, N., & Hosseinzadeh, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212171 · Cited by 55
“For the studies that failed to see statistically significant intergroup differences in mean HbA1c, some statistically significant improvements were seen in secondary outcome measures including a reduction in outpatient, Emergency Department (ED) visits as well as planned hospitalisations [38], and a significant reduct…”
ResultInfluential
Metadata
- Authors
- Dario, C., Toffanin, R., Calcaterra, F., Saccavini, C., Stafylas, P., Mancin, S., & Vio, E.
- Venue
- Telemedicine and e-Health
- Publisher
- SAGE Publications
- Published
- 2017-02
- Volume
- 23
- Issue
- 2
- Pages
- 143-152
- ISSN
- 1530-5627 (ISSN-L)
- 1556-3669
- OpenAlex
- W2470199751
- Cited by
- 39
- References
- 7
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telemonitoring of Type 2 Diabetes Mellitus in Italy. https://app.cochat.ai/papers/10.1089/tmj.2015.0224
- The paper
- Dario, C., Toffanin, R., Calcaterra, F., Saccavini, C., Stafylas, P., Mancin, S., & Vio, E. (2017). Telemonitoring of Type 2 Diabetes Mellitus in Italy. Telemedicine and e-Health. https://doi.org/10.1089/tmj.2015.0224
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.